Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03281798 · ClinicalTrials.gov registry record · NA

Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction

A NA study of Lower Urinary Tract Obstructive Syndrome and Bladder Outlet Obstruction, sponsored by Rodrigo Ruano.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
2
Study locations

NCT03281798: Recruiting NA study of Lower Urinary Tract Obstructive Syndrome and Bladder Outlet Obstruction, sponsored by Rodrigo Ruano.

NCT03281798 is a NA study of Lower Urinary Tract Obstructive Syndrome and Bladder Outlet Obstruction that is actively recruiting participants, run by Rodrigo Ruano. The registered enrollment target is 10 participants, below the 48-participant average among 3 other Lower Urinary Tract Obstructive Syndrome trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03281798, a NA study of Lower Urinary Tract Obstructive Syndrome and Bladder Outlet Obstruction, is actively recruiting participants, sponsored by Rodrigo Ruano.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
2
Study locations

Study Summary

The purpose of the study is to study the outcomes of maternal and fetal patients who are undergoing fetal intervention for severe isolated lower urinary tract obstruction (LUTO).

Primary Outcome

Number of participants where the fetal cystoscopy procedure was successfully technically performed.

Interventions

  • DEVICE Fetoscopes
  • PROCEDURE Fetal Cystoscopy

Study Locations (2)

Florida

  • University of Miami - Miami

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2018-01-01
Est. Completion 2028-08-01
Phase NA
Rodrigo Ruano

3 total trials

What NCT03281798 shows while recruiting

NCT03281798 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 48-participant average among 3 other Lower Urinary Tract Obstructive Syndrome trials with a reported enrollment target (79% lower).

The record links to 4 conditions, with Lower Urinary Tract Obstructive Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Fetoscopes is the first listed.

NCT03281798 reports a single indexed study location in Florida, Minnesota.

Frequently Asked Questions

What is clinical trial NCT03281798 about?

NCT03281798 is a clinical study titled "Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction". The purpose of the study is to study the outcomes of maternal and fetal patients who are undergoing fetal intervention for severe isolated lower urinary tract obstruction (LUTO).

What is the current status of trial NCT03281798?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2018-01-01. Estimated completion is 2028-08-01.

What conditions does trial NCT03281798 study?

This clinical trial studies the following conditions: Lower Urinary Tract Obstructive Syndrome, Bladder Outlet Obstruction, Lower Urinary Tract Obstruction, Congenital, Bladder Outflow Obstruction.

What interventions are being tested in trial NCT03281798?

The interventions under investigation include: Fetoscopes (DEVICE), Fetal Cystoscopy (PROCEDURE).

Who is sponsoring clinical trial NCT03281798?

This trial is sponsored by Rodrigo Ruano, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03281798 being conducted?

This trial has 2 study locations across Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lower Urinary Tract Obstructive Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03281798, the US trial registry maintained by the National Library of Medicine. NCT03281798 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.